CURAA vs RPTECH: Stock Comparison

CURAA vs RASHI PERIPHERALSUpdated 17 Sept 26, 4:08 PM ISTNSE & company filings

RASHI PERIPHERALS is the larger company by market capitalisation. RASHI PERIPHERALS shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

CURAA leads 1; RPTECH leads 10 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

CURAARPTECH

Valuation lens

What price are you paying?

Market CapContext only
₹73 Cr
₹5,241 Cr
P/E RatioSame reading
16.43x
P/B RatioSame reading
2.59x
EPSRPTECH has the higher reading
₹-0.28
₹15.59
Book ValueContext only
₹6.45
₹308.99
Dividend YieldRPTECH has the higher reading
0%
0.25%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
RPTECH is the larger company
₹5,241 Cr vs ₹73 Cr
EPS
RPTECH has higher earnings per share
₹15.59 vs ₹-0.28
Dividend Yield
RPTECH has a higher dividend yield
0.25% vs 0%
Revenue Growth (TTM YoY)
RPTECH has faster revenue growth
51% vs 0%
EPS Growth (TTM YoY)
RPTECH has faster EPS growth
60.6% vs 0%
Qtr Sales Growth
RPTECH has stronger quarterly sales growth
5.58% vs -94.23%
Qtr Profit Growth
CURAA has stronger quarterly profit growth
81.29% vs 7.63%
ROE
RPTECH has a higher ROE
13.16% vs -23.25%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricCURAARPTECH
SectorInformation TechnologyInformation Technology
IndustryComputers - Software & ConsultingComputers Hardware & Equipments

Price

MetricCURAARPTECH
Live Price₹72.94₹798.05
Day Change-2.75%-1.08%
Volume7841.63 L
52-Week High₹93.95₹967.7
52-Week Low₹60₹310.8
Distance from 52W High-22.36%-17.53%

Valuation

MetricCURAARPTECH
Market Cap₹73 Cr₹5,241 Cr
P/E Ratio16.43x
P/B Ratio2.59x
EPS₹-0.28₹15.59
Book Value₹6.45₹308.99
Dividend Yield0%0.25%

Growth

MetricCURAARPTECH
Revenue Growth (TTM YoY)0%51%
EPS Growth (TTM YoY)0%60.6%
Qtr Sales Growth-94.23%5.58%
Qtr Profit Growth81.29%7.63%

Profitability & Leverage

MetricCURAARPTECH
ROE-23.25%13.16%
ROCE-8.79%11.65%
Net Margin-177.78%1.75%
Operating Margin-110.37%2.99%
Debt to Equity0.95x0.48x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricCURAARPTECH
Promoter Holding74.95%64.03% 0.02 pp
FII Holding3.27% 2.49 pp
DII Holding0.03%12.67% 4.78 pp
Public Holding25.02%20.02% 2.26 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: CURAA and RASHI PERIPHERALS.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.